Article info

Original research
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations

Authors

  1. Correspondence to Professor Peter C Taylor; peter.taylor{at}kennedy.ox.ac.uk
View Full Text

Citation

Kaneko K, Prieto-Alhambra D, Jacklin C, et al
Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations

Publication history

  • Received March 10, 2021
  • Accepted January 28, 2022
  • First published February 16, 2022.
Online issue publication 
February 16, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.